XML 292 R53.htm IDEA: XBRL DOCUMENT v3.25.2
STOCK PROGRAMS (Tables)
 12 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of stock-based compensation expense
Total net stock-based compensation expense is attributable to the granting of and the remaining requisite service periods of stock options, RSUs, PSUs, long-term PSUs and share units. Compensation expense attributable to net stock-based compensation is as follows:
Year Ended June 30,
(In millions)202520242023
Compensation expense(1)
$304 $325 $267 
Income tax benefit$58 $58 $52 
(1)Excludes compensation expense relating to liability-classified awards, including DECIEM stock options discussed below.
Summary of stock option programs
The following is a summary of the status of the Company’s stock options as of June 30, 2025 and activity during the fiscal year then ended:
(Shares in thousands)SharesWeighted-
Average
Exercise
Price Per Share
Aggregate
Intrinsic
Value(1)
(in millions)
Weighted-Average
Contractual Life
Remaining in Years
Outstanding at June 30, 2024
8,495.7 $182.95 
Granted at fair value885.2 90.93 
Exercised(207.2)76.47 
Expired(308.3)220.20 
Forfeited(178.9)162.77 
Outstanding at June 30, 2025
8,686.5 175.21 $3 5.0
Vested and expected to vest at June 30, 2025
8,653.2 175.33 $3 5.0
Exercisable at June 30, 2025
6,761.9 183.72 $2 4.0
(1)The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price of the option.
Summary of weighted-average grant date fair value and intrinsic value of stock options exercised
The following is a summary of the per-share weighted-average grant date fair value of stock options granted and total intrinsic value of stock options exercised:
Year Ended June 30,
(In millions, except per share data)202520242023
Per-share weighted-average grant date fair value of stock options granted$29.24 $52.83 $79.09 
Intrinsic value of stock options exercised$3 $31 $93 
Schedule of fair value option-pricing assumptions
The fair value of each of the Company's option grants were estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions:
 
Year Ended June 30,
 202520242023
Weighted-average expected stock-price volatility37.5%33.8%30.8%
Weighted-average expected option life6 years6 years6 years
Average risk-free interest rate3.6%4.3%3.4%
Average dividend yield2.4%1.5%0.8%
Summary of restricted stock units (RSUs)
The following is a summary of the status of the Company’s RSUs as of June 30, 2025 and activity during the fiscal year then ended:
(Shares in thousands)SharesWeighted-Average
Grant Date
Fair Value Per Share
Nonvested at June 30, 2024
2,442.5 $196.69 
Granted3,371.5 91.82 
Dividend equivalents93.6 124.97 
Vested(1)
(1,136.4)218.71 
Forfeited(469.4)121.62 
Nonvested at June 30, 2025
4,301.8 115.31 
1) The total fair value of RSUs vested during fiscal 2025, 2024 and 2023 was $78 million, $92 million, and $156 million, respectively.
Summary of performance share units (PSUs) The following is a summary of the status of the Company’s PSUs as of June 30, 2025 and activity during the fiscal year then ended:
(Shares in thousands)SharesWeighted-Average
Grant Date
Fair Value Per Share
Nonvested at June 30, 2024
373.9 $232.83 
Granted365.1 92.02 
Vested and issued(1)
— — 
Forfeited(117.7)286.65 
Nonvested at June 30, 2025
621.3 139.87 
(1) The total fair value of PSUs vested and issued during fiscal 2024 and 2023 was $7 million and $67 million, respectively.
Schedule of long-term price vested units
The number of shares subject to each tranche of the price-vested unit award, as well as the stock price goals, service periods, performance periods and share delivery dates for each tranche are as follows:
Number
of
Shares
per
Tranche		Stock Price Goal
(per Share)		Service PeriodPerformance Period for Stock Price GoalPerformance Period for Cumulative Operating Income GoalShare Delivery Date
First tranche27,457 $323.03 March 11, 2021 - June 30, 2024March 11, 2021 - June 30, 2024July 1, 2021 - June 30, 2025September 2, 2025
Second tranche28,598 $333.21 March 11, 2021 - June 30, 2024March 11, 2021 - June 30, 2024July 1, 2021 - June 30, 2025September 2, 2025
Third tranche29,872 $343.61 March 11, 2021 - June 30, 2024March 11, 2021 - June 30, 2024July 1, 2021 - June 30, 2025September 2, 2025
Total shares85,927 
Schedule of assumptions used for Long-term Price-Vested Units The significant assumptions used for this award were as follows:
Expected volatility31.8 %
Dividend yield0.8 %
Risk-free interest rate0.4 %
Expected term3.3 years
Summary of status of share units
The following is a summary of the status of the Company’s share units as of June 30, 2025 and activity during the fiscal year then ended:
(Shares in thousands)SharesWeighted-Average
Grant Date
Fair Value Per Share
Outstanding at June 30, 2024113.6 $90.02 
Granted12.0 63.90 
Dividend equivalents2.5 78.85 
Converted (1)
(21.2)73.35 
Outstanding at June 30, 2025106.9 90.15 
(1) The total intrinsic value of share units converted during fiscal 2025, 2024 and 2023 was $1.6 million, $1.5 million, and $4.1 million, respectively.